Skip to main content
Back to Blog
Technology

The 24 Data Sources Behind Contextual Intelligence

By Contextual IntelligenceJanuary 1, 2026~6 min read

Explore the 24 global regulatory, clinical, patent, grant, and market databases that power the Contextual Intelligence platform. FDA, EUDAMED, ANVISA, NMPA, PitchBook, and more.

Data Source Architecture

Contextual Intelligence ingests data from 24 distinct sources organized into five domains: regulatory authorities, patent offices, clinical trial registries, grants and funding databases, and market intelligence feeds. Each source is monitored on its own crawl schedule, from daily for high-volume regulatory sources to weekly for patent databases and grant repositories.

The platform processes over 18,000 signals per day across all sources, with an average detection latency of under 12 hours from source publication to signal availability. Our entity resolution engine cross-references company names, device identifiers, personnel, and grant recipients across sources to build unified organizational profiles from fragmented data.

Regulatory Data Sources

Regulatory data forms the backbone of our signal detection platform. We monitor 10 regulatory authorities across North America, Europe, Asia-Pacific, and Latin America, covering the world's largest and most influential medical device markets.

FDA (USA)

The US Food and Drug Administration is the world's most influential medical device regulator. We monitor FDA 510(k) clearances, PMA approvals, De Novo classifications, recall announcements, and establishment registration updates. Update frequency: daily. Average signal volume: 200+ per week.

EUDAMED (European Union)

The European Database on Medical Devices is the central repository for EU MDR and IVDR compliance data. We monitor NB certificate issuances, UDI device registrations, vigilance data, and market surveillance notices. Update frequency: daily. Average signal volume: 150+ per week.

ANVISA (Brazil)

Brazil's national health surveillance agency manages the largest medical device market in Latin America. We monitor device registration approvals, GMP certifications, and regulatory updates. Update frequency: daily. Average signal volume: 80+ per week.

NMPA (China)

China's National Medical Products Administration oversees the world's second-largest medical device market. We monitor device registration certificates, change notifications, and import license updates. Update frequency: daily. Average signal volume: 100+ per week.

PMDA (Japan)

The Pharmaceuticals and Medical Devices Agency is Japan's medical device regulatory body. We monitor Shonin marketing approval certificates, classification decisions, and safety updates. Update frequency: daily. Average signal volume: 60+ per week.

CDSCO (India)

India's Central Drugs Standard Control Organization regulates devices in one of the fastest-growing healthcare markets. We monitor import licenses, device registrations, and regulatory notifications. Update frequency: weekly. Average signal volume: 40+ per week.

MFDS (South Korea)

South Korea's Ministry of Food and Drug Safety regulates medical devices in a sophisticated and rapidly aging market. We monitor device approvals, clinical trial authorizations, and GMP certifications. Update frequency: weekly. Average signal volume: 50+ per week.

TGA (Australia)

The Therapeutic Goods Administration maintains the Australian Register of Therapeutic Goods (ARTG). We monitor new ARTG entries, certificate changes, and conformity assessment updates. Update frequency: daily. Average signal volume: 30+ per week.

Health Canada

Health Canada's Medical Devices Directorate licenses all medical devices sold in Canada. We monitor Medical Device License (MDL) issuances, MDEL registrations, and safety alerts. Update frequency: daily. Average signal volume: 40+ per week.

WHO Prequalification

The World Health Organization's Prequalification Program evaluates medical devices and IVDs for global health procurement. We monitor PQ listings, inspection outcomes, and performance reports. Update frequency: weekly. Average signal volume: 10+ per week.

Patent Data Sources

Patent data provides early visibility into R&D activity before regulatory submissions appear. Our platform monitors six major patent offices, covering the vast majority of global medical device and IVD patent filings.

USPTO

United States Patent and Trademark Office. Coverage: granted patents and published applications. Update frequency: weekly.

EPO

European Patent Office. Coverage: European patent grants and applications. Update frequency: weekly.

WIPO

World Intellectual Property Organization. Coverage: PCT international applications. Update frequency: weekly.

CNIPA

China National Intellectual Property Administration. Coverage: Chinese patent filings. Update frequency: weekly.

KIPO

Korean Intellectual Property Office. Coverage: South Korean patent filings. Update frequency: weekly.

JPO

Japan Patent Office. Coverage: Japanese patent filings. Update frequency: weekly.

Clinical Trial Data Sources

Clinical trial activity is a leading indicator of product development progress and eventual regulatory submission. We monitor the two most comprehensive clinical trial registries globally.

ClinicalTrials.gov

The US National Library of Medicine's clinical trials registry is the world's largest, with over 450,000 registered studies from 220+ countries. We monitor new trial registrations, status changes, and results submissions for medical device and IVD studies. Update frequency: daily. Average signal volume: 200+ per week.

EU CTIS

The EU Clinical Trials Information System is the single entry point for clinical trial authorization under the EU Clinical Trial Regulation. We monitor trial applications, authorizations, and results for device and IVD studies. Update frequency: daily. Average signal volume: 80+ per week.

Grants and Funding Data Sources

Grant and funding signals reveal where R&D investment is flowing before products reach the market. Government grants validate technology readiness, while private funding signals strategic direction and growth trajectory. These sources bridge the gap between early-stage research and commercial regulatory activity.

Grants.gov

The US federal grants portal. We monitor SBIR/STTR awards and NIH grant funding relevant to medical device and diagnostic development. Grant recipients represent validated technology with non-dilutive funding. Update frequency: weekly.

NIH RePORTER

The NIH Research Portfolio Online Reporting Tools database provides detailed information on NIH-funded research projects. We monitor awarded grants, research progress reports, and funding trends across institutes and centers. This source offers a broader view of federal research investment beyond the SBIR/STTR programs tracked in Grants.gov. Update frequency: weekly.

Market Intelligence Data Sources

Market intelligence signals provide context on company financial health, competitive positioning, and strategic direction. These sources complement regulatory, clinical, and grant data to build a complete picture of every organization in our platform.

Crunchbase

Leading platform for company funding data, including venture capital rounds, acquisitions, and IPOs in the MedTech and health technology sectors. Update frequency: daily.

PitchBook

Comprehensive private market database covering venture capital, private equity, M&A transactions, and IPO activity in healthcare and life sciences. PitchBook provides deeper coverage of later-stage private company activity and detailed financial metrics. Update frequency: daily.

SEC EDGAR

The SEC's Electronic Data Gathering, Analysis, and Retrieval system provides public company disclosures including 10-K annual reports, 8-K current reports, and S-1 registration statements. Update frequency: daily.

PubMed

The National Library of Medicine's database of biomedical literature. We monitor publications relevant to medical devices and IVDs, including clinical studies, systematic reviews, and health technology assessments. Update frequency: weekly.

Data Processing and Entity Resolution

Raw data from global public sources is useless without intelligent processing. Our data pipeline performs several critical transformations: normalization of data formats from each source, de-duplication of records across sources (e.g., the same company appearing in FDA, ClinicalTrials.gov, and Crunchbase), entity resolution linking company names across languages and variations, and enrichment layering that combines regulatory, clinical, patent, grant, and market data into unified organizational profiles.

The entity resolution engine is particularly critical. A company called "BioDiagnostics Inc." in FDA records may appear as "Bio-Diagnostics, Inc." in ClinicalTrials.gov and "BioDiagnostics" on Crunchbase. Our resolution algorithms use fuzzy matching, address verification, and relationship graph analysis to unify these references into a single company entity.

Coverage Frequency and Data Freshness

Data freshness is critical for signal intelligence. Our sources are crawled on schedules tailored to their publication patterns:

Crawl Schedule by Source Category

  • Daily (13 sources): FDA, EUDAMED, ANVISA, NMPA, PMDA, TGA, Health Canada, ClinicalTrials.gov, EU CTIS, SEC EDGAR, Crunchbase, PitchBook, Grants.gov
  • Weekly (11 sources): CDSCO, MFDS, WHO PQ, USPTO, EPO, WIPO, CNIPA, KIPO, JPO, PubMed, NIH RePORTER

Schedules are subject to change based on source API availability and data volume.

The result is a continuously updated intelligence feed that detects signals within hours of publication, not days or weeks. For organizations monitoring competitive activity, partnership opportunities, or market trends, this speed differential translates directly into first-mover advantage.

Each data source undergoes quarterly quality reviews to ensure coverage completeness, data accuracy, and detection latency meet our platform standards. When sources change their data formats or availability, our engineering team prioritizes rapid adaptation to maintain uninterrupted signal coverage.

Explore the CI Platform

See how signal intelligence can transform your regulatory, competitive, and market intelligence

Book a Demo

Share this article